RESI 2023 (In person and Virtual)

Location: Boston


Event description:

DATE: June 5 (in person) June 6 & 7 (virtual)

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners across the lifescience and healthcare industry.

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme. Our Novotech clinical team have almost 20 years’ experience working on 500+ early phase studies, making us an exceptionally experienced local provider within the Australian & New Zealand market and a partner of choice for many international biotech companies.

Schedule a meeting with our attendees

Meet Our Team


John Moller

Chief Executive Officer

Barry Murphy

Chief Commercial Officer
Novotech China

Andy Liu

Novotech China
Head of China

Plus team members from our Novotech China, Novotech DDC and US BD teams